Cargando…
BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas
SIMPLE SUMMARY: Uveal melanoma is a highly metastatic cancer of the eye which is notoriously resistant to therapy. Elucidating the mechanisms of metastasis in order to devise effective therapies has been a major challenge. The strongest genetic risk factor for metastasis in uveal melanoma is the mut...
Autores principales: | Kaler, Christopher J., Dollar, James J., Cruz, Anthony M., Kuznetsoff, Jeffim N., Sanchez, Margaret I., Decatur, Christina L., Licht, Jonathan D., Smalley, Keiran S. M., Correa, Zelia M., Kurtenbach, Stefan, Harbour, J. William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367253/ https://www.ncbi.nlm.nih.gov/pubmed/35954340 http://dx.doi.org/10.3390/cancers14153678 |
Ejemplares similares
-
PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023) -
RB1 loss triggers dependence on ESRRG in retinoblastoma
por: Field, Matthew G., et al.
Publicado: (2022) -
BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers
por: Kuznetsov, Jeffim N., et al.
Publicado: (2019) -
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
por: Field, Matthew G., et al.
Publicado: (2016) -
Single-cell analysis reveals new evolutionary complexity in uveal melanoma
por: Durante, Michael A., et al.
Publicado: (2020)